This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 May;16(5):1188-94.

doi: 10.1681/ASN.2005010028. Epub 2005 Mar 30.

Management of membranous nephropathy: when and what for treatment

Daniel Cattran¹

Affiliations

Affiliation

¹ Toronto General Research Institute, University Health Network, Toronto General Hospital, NCSB 11-1256, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada. daniel.cattran@uhn.on.ca

PMID: 15800117
DOI: 10.1681/ASN.2005010028

Review

Management of membranous nephropathy: when and what for treatment

Daniel Cattran. J Am Soc Nephrol. 2005 May.

. 2005 May;16(5):1188-94.

doi: 10.1681/ASN.2005010028. Epub 2005 Mar 30.

Author

Daniel Cattran¹

Affiliation

¹ Toronto General Research Institute, University Health Network, Toronto General Hospital, NCSB 11-1256, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada. daniel.cattran@uhn.on.ca

PMID: 15800117
DOI: 10.1681/ASN.2005010028

No abstract available

PubMed Disclaimer

Similar articles

[Treatment of extra-membranous glomerulonephritis with immunosuppressive agents or difficulties of meta-analysis in nephrology].
Couchoud C, Laville M, Boissel JP. Couchoud C, et al. Therapie. 1994 May-Jun;49(3):171-3. Therapie. 1994. PMID: 7878579 French. No abstract available.
[Treatment of membranous glomerulonephritis: analysis of data from the Italian Renal Biopsy Registry].
Garozzo M, Puliatti D, Battaglia GG. Garozzo M, et al. G Ital Nefrol. 2011 Jul-Aug;28(4):425-30. G Ital Nefrol. 2011. PMID: 21809312 Italian.
[Immunosuppression in membranous glomerulonephritis - contra].
Wüthrich RP. Wüthrich RP. Dtsch Med Wochenschr. 2009 Aug;134(34-35):1687. doi: 10.1055/s-0029-1234002. Epub 2009 Aug 25. Dtsch Med Wochenschr. 2009. PMID: 19707966 German. No abstract available.
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
Hofstra JM, Wetzels JF. Hofstra JM, et al. Nephrol Dial Transplant. 2010 Jun;25(6):1760-6. doi: 10.1093/ndt/gfq017. Epub 2010 Feb 3. Nephrol Dial Transplant. 2010. PMID: 20133280 Review. No abstract available.
Idiopathic membranous nephropathy: new therapeutic trends.
Rostoker G. Rostoker G. Eur J Med. 1993 Feb;2(2):106-16. Eur J Med. 1993. PMID: 8258013 Review. No abstract available.

See all similar articles

Cited by

THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury.
Liu J, Malhotra D, Ge Y, Gunning W, Dworkin L, Gong R. Liu J, et al. Front Pharmacol. 2024 Jul 17;15:1430451. doi: 10.3389/fphar.2024.1430451. eCollection 2024. Front Pharmacol. 2024. PMID: 39086386 Free PMC article.
Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
Sprangers B, Lefkowitz GI, Cohen SD, Stokes MB, Valeri A, Appel GB, Kunis CL. Sprangers B, et al. Clin J Am Soc Nephrol. 2010 May;5(5):790-7. doi: 10.2215/CJN.04120609. Epub 2010 Feb 25. Clin J Am Soc Nephrol. 2010. PMID: 20185599 Free PMC article.
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.
Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC; Mayo Nephrology Collaborative Group. Fervenza FC, et al. Clin J Am Soc Nephrol. 2010 Dec;5(12):2188-98. doi: 10.2215/CJN.05080610. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705965 Free PMC article.
Novel biomarkers in glomerular disease.
Caliskan Y, Kiryluk K. Caliskan Y, et al. Adv Chronic Kidney Dis. 2014 Mar;21(2):205-16. doi: 10.1053/j.ackd.2013.12.002. Adv Chronic Kidney Dis. 2014. PMID: 24602470 Free PMC article. Review.
Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy.
Lee SM, Yang S, Cha RH, Kim M, An JN, Paik JH, Kim DK, Kang SW, Lim CS, Kim YS, Lee JP. Lee SM, et al. PLoS One. 2014 Aug 6;9(8):e104354. doi: 10.1371/journal.pone.0104354. eCollection 2014. PLoS One. 2014. PMID: 25098821 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Wolters Kluwer
Medical
- ClinicalTrials.gov